nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—Carmustine—lymphatic system cancer	0.226	0.366	CbGbCtD
Anastrozole—CYP2C9—Teniposide—lymphatic system cancer	0.137	0.222	CbGbCtD
Anastrozole—CYP3A4—Cytarabine—lymphatic system cancer	0.0807	0.131	CbGbCtD
Anastrozole—CYP3A4—Teniposide—lymphatic system cancer	0.0795	0.129	CbGbCtD
Anastrozole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0556	0.0902	CbGbCtD
Anastrozole—CYP3A4—Vincristine—lymphatic system cancer	0.0383	0.0621	CbGbCtD
Anastrozole—Nausea—Mechlorethamine—lymphatic system cancer	0.000904	0.00236	CcSEcCtD
Anastrozole—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000902	0.00235	CcSEcCtD
Anastrozole—Alopecia—Bleomycin—lymphatic system cancer	0.000899	0.00234	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000898	0.00234	CcSEcCtD
Anastrozole—Jaundice—Mitoxantrone—lymphatic system cancer	0.000897	0.00234	CcSEcCtD
Anastrozole—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.000894	0.00233	CcSEcCtD
Anastrozole—Haemoglobin—Carmustine—lymphatic system cancer	0.000893	0.00233	CcSEcCtD
Anastrozole—Urticaria—Teniposide—lymphatic system cancer	0.000891	0.00232	CcSEcCtD
Anastrozole—Haemorrhage—Carmustine—lymphatic system cancer	0.000888	0.00232	CcSEcCtD
Anastrozole—Abdominal pain—Teniposide—lymphatic system cancer	0.000887	0.00231	CcSEcCtD
Anastrozole—Body temperature increased—Teniposide—lymphatic system cancer	0.000887	0.00231	CcSEcCtD
Anastrozole—Erythema—Bleomycin—lymphatic system cancer	0.000886	0.00231	CcSEcCtD
Anastrozole—Paraesthesia—Fludarabine—lymphatic system cancer	0.000886	0.00231	CcSEcCtD
Anastrozole—Sweating—Mitoxantrone—lymphatic system cancer	0.000882	0.0023	CcSEcCtD
Anastrozole—Dyspnoea—Fludarabine—lymphatic system cancer	0.000879	0.00229	CcSEcCtD
Anastrozole—Oedema peripheral—Carmustine—lymphatic system cancer	0.000875	0.00228	CcSEcCtD
Anastrozole—Dyspepsia—Fludarabine—lymphatic system cancer	0.000868	0.00226	CcSEcCtD
Anastrozole—Ulcer—Methotrexate—lymphatic system cancer	0.000866	0.00226	CcSEcCtD
Anastrozole—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000863	0.00225	CcSEcCtD
Anastrozole—Decreased appetite—Fludarabine—lymphatic system cancer	0.000857	0.00223	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000851	0.00222	CcSEcCtD
Anastrozole—Fatigue—Fludarabine—lymphatic system cancer	0.00085	0.00222	CcSEcCtD
Anastrozole—Inflammation—Methotrexate—lymphatic system cancer	0.000845	0.0022	CcSEcCtD
Anastrozole—Constipation—Fludarabine—lymphatic system cancer	0.000843	0.0022	CcSEcCtD
Anastrozole—Pain—Fludarabine—lymphatic system cancer	0.000843	0.0022	CcSEcCtD
Anastrozole—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00083	0.00216	CcSEcCtD
Anastrozole—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000828	0.00216	CcSEcCtD
Anastrozole—Hypersensitivity—Teniposide—lymphatic system cancer	0.000827	0.00215	CcSEcCtD
Anastrozole—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000826	0.00215	CcSEcCtD
Anastrozole—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000826	0.00215	CcSEcCtD
Anastrozole—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000822	0.00214	CcSEcCtD
Anastrozole—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00082	0.00214	CcSEcCtD
Anastrozole—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000819	0.00214	CcSEcCtD
Anastrozole—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.000819	0.00214	CcSEcCtD
Anastrozole—Anaemia—Bleomycin—lymphatic system cancer	0.000819	0.00213	CcSEcCtD
Anastrozole—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000813	0.00212	CcSEcCtD
Anastrozole—Asthenia—Teniposide—lymphatic system cancer	0.000805	0.0021	CcSEcCtD
Anastrozole—Malaise—Bleomycin—lymphatic system cancer	0.000799	0.00208	CcSEcCtD
Anastrozole—Pruritus—Teniposide—lymphatic system cancer	0.000794	0.00207	CcSEcCtD
Anastrozole—Leukopenia—Bleomycin—lymphatic system cancer	0.000793	0.00207	CcSEcCtD
Anastrozole—Alopecia—Carmustine—lymphatic system cancer	0.000785	0.00205	CcSEcCtD
Anastrozole—Body temperature increased—Fludarabine—lymphatic system cancer	0.00078	0.00203	CcSEcCtD
Anastrozole—Vaginal infection—Methotrexate—lymphatic system cancer	0.000774	0.00202	CcSEcCtD
Anastrozole—Erythema—Carmustine—lymphatic system cancer	0.000773	0.00202	CcSEcCtD
Anastrozole—Cough—Bleomycin—lymphatic system cancer	0.000773	0.00201	CcSEcCtD
Anastrozole—Diarrhoea—Teniposide—lymphatic system cancer	0.000768	0.002	CcSEcCtD
Anastrozole—Chest pain—Bleomycin—lymphatic system cancer	0.000754	0.00197	CcSEcCtD
Anastrozole—Myalgia—Bleomycin—lymphatic system cancer	0.000754	0.00197	CcSEcCtD
Anastrozole—Alopecia—Vincristine—lymphatic system cancer	0.000749	0.00195	CcSEcCtD
Anastrozole—Back pain—Carmustine—lymphatic system cancer	0.000748	0.00195	CcSEcCtD
Anastrozole—Discomfort—Bleomycin—lymphatic system cancer	0.000745	0.00194	CcSEcCtD
Anastrozole—Neoplasm—Methotrexate—lymphatic system cancer	0.000741	0.00193	CcSEcCtD
Anastrozole—Alopecia—Mitoxantrone—lymphatic system cancer	0.00073	0.0019	CcSEcCtD
Anastrozole—Confusional state—Bleomycin—lymphatic system cancer	0.000729	0.0019	CcSEcCtD
Anastrozole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000727	0.00189	CcSEcCtD
Anastrozole—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000723	0.00188	CcSEcCtD
Anastrozole—Oedema—Bleomycin—lymphatic system cancer	0.000723	0.00188	CcSEcCtD
Anastrozole—Erythema—Mitoxantrone—lymphatic system cancer	0.000719	0.00187	CcSEcCtD
Anastrozole—Infection—Bleomycin—lymphatic system cancer	0.000718	0.00187	CcSEcCtD
Anastrozole—Anaemia—Carmustine—lymphatic system cancer	0.000715	0.00186	CcSEcCtD
Anastrozole—Back pain—Vincristine—lymphatic system cancer	0.000714	0.00186	CcSEcCtD
Anastrozole—Vomiting—Teniposide—lymphatic system cancer	0.000713	0.00186	CcSEcCtD
Anastrozole—Asthenia—Fludarabine—lymphatic system cancer	0.000708	0.00184	CcSEcCtD
Anastrozole—Rash—Teniposide—lymphatic system cancer	0.000707	0.00184	CcSEcCtD
Anastrozole—Dermatitis—Teniposide—lymphatic system cancer	0.000707	0.00184	CcSEcCtD
Anastrozole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000704	0.00183	CcSEcCtD
Anastrozole—Headache—Teniposide—lymphatic system cancer	0.000703	0.00183	CcSEcCtD
Anastrozole—Pruritus—Fludarabine—lymphatic system cancer	0.000698	0.00182	CcSEcCtD
Anastrozole—Back pain—Mitoxantrone—lymphatic system cancer	0.000695	0.00181	CcSEcCtD
Anastrozole—Leukopenia—Carmustine—lymphatic system cancer	0.000692	0.0018	CcSEcCtD
Anastrozole—Anorexia—Bleomycin—lymphatic system cancer	0.000689	0.0018	CcSEcCtD
Anastrozole—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000687	0.00179	CcSEcCtD
Anastrozole—Anaemia—Vincristine—lymphatic system cancer	0.000682	0.00178	CcSEcCtD
Anastrozole—Diarrhoea—Fludarabine—lymphatic system cancer	0.000675	0.00176	CcSEcCtD
Anastrozole—Hypertension—Carmustine—lymphatic system cancer	0.000668	0.00174	CcSEcCtD
Anastrozole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000667	0.00174	CcSEcCtD
Anastrozole—Nausea—Teniposide—lymphatic system cancer	0.000666	0.00174	CcSEcCtD
Anastrozole—Anaemia—Mitoxantrone—lymphatic system cancer	0.000664	0.00173	CcSEcCtD
Anastrozole—Leukopenia—Vincristine—lymphatic system cancer	0.000661	0.00172	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000659	0.00172	CcSEcCtD
Anastrozole—Chest pain—Carmustine—lymphatic system cancer	0.000658	0.00172	CcSEcCtD
Anastrozole—Myalgia—Carmustine—lymphatic system cancer	0.000658	0.00172	CcSEcCtD
Anastrozole—Anxiety—Carmustine—lymphatic system cancer	0.000656	0.00171	CcSEcCtD
Anastrozole—Paraesthesia—Bleomycin—lymphatic system cancer	0.000649	0.00169	CcSEcCtD
Anastrozole—Malaise—Mitoxantrone—lymphatic system cancer	0.000648	0.00169	CcSEcCtD
Anastrozole—Dyspnoea—Bleomycin—lymphatic system cancer	0.000645	0.00168	CcSEcCtD
Anastrozole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000644	0.00168	CcSEcCtD
Anastrozole—Hypertension—Vincristine—lymphatic system cancer	0.000637	0.00166	CcSEcCtD
Anastrozole—Confusional state—Carmustine—lymphatic system cancer	0.000636	0.00166	CcSEcCtD
Anastrozole—Oedema—Carmustine—lymphatic system cancer	0.000631	0.00165	CcSEcCtD
Anastrozole—Decreased appetite—Bleomycin—lymphatic system cancer	0.000629	0.00164	CcSEcCtD
Anastrozole—Myalgia—Vincristine—lymphatic system cancer	0.000628	0.00164	CcSEcCtD
Anastrozole—Cough—Mitoxantrone—lymphatic system cancer	0.000627	0.00164	CcSEcCtD
Anastrozole—Infection—Carmustine—lymphatic system cancer	0.000627	0.00163	CcSEcCtD
Anastrozole—Vomiting—Fludarabine—lymphatic system cancer	0.000627	0.00163	CcSEcCtD
Anastrozole—Rash—Fludarabine—lymphatic system cancer	0.000622	0.00162	CcSEcCtD
Anastrozole—Dermatitis—Fludarabine—lymphatic system cancer	0.000621	0.00162	CcSEcCtD
Anastrozole—Hypertension—Mitoxantrone—lymphatic system cancer	0.000621	0.00162	CcSEcCtD
Anastrozole—Pain—Bleomycin—lymphatic system cancer	0.000618	0.00161	CcSEcCtD
Anastrozole—Headache—Fludarabine—lymphatic system cancer	0.000618	0.00161	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000615	0.0016	CcSEcCtD
Anastrozole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000612	0.0016	CcSEcCtD
Anastrozole—Myalgia—Mitoxantrone—lymphatic system cancer	0.000612	0.0016	CcSEcCtD
Anastrozole—Chest pain—Mitoxantrone—lymphatic system cancer	0.000612	0.0016	CcSEcCtD
Anastrozole—Anxiety—Mitoxantrone—lymphatic system cancer	0.00061	0.00159	CcSEcCtD
Anastrozole—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000607	0.00158	CcSEcCtD
Anastrozole—Lethargy—Methotrexate—lymphatic system cancer	0.000607	0.00158	CcSEcCtD
Anastrozole—Discomfort—Mitoxantrone—lymphatic system cancer	0.000605	0.00158	CcSEcCtD
Anastrozole—Oedema—Vincristine—lymphatic system cancer	0.000602	0.00157	CcSEcCtD
Anastrozole—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000602	0.00157	CcSEcCtD
Anastrozole—Anorexia—Carmustine—lymphatic system cancer	0.000602	0.00157	CcSEcCtD
Anastrozole—Infection—Vincristine—lymphatic system cancer	0.000599	0.00156	CcSEcCtD
Anastrozole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000596	0.00155	CcSEcCtD
Anastrozole—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000595	0.00155	CcSEcCtD
Anastrozole—Confusional state—Mitoxantrone—lymphatic system cancer	0.000592	0.00154	CcSEcCtD
Anastrozole—Oedema—Mitoxantrone—lymphatic system cancer	0.000587	0.00153	CcSEcCtD
Anastrozole—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000587	0.00153	CcSEcCtD
Anastrozole—Nausea—Fludarabine—lymphatic system cancer	0.000586	0.00153	CcSEcCtD
Anastrozole—Infection—Mitoxantrone—lymphatic system cancer	0.000583	0.00152	CcSEcCtD
Anastrozole—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000582	0.00152	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000575	0.0015	CcSEcCtD
Anastrozole—Urticaria—Bleomycin—lymphatic system cancer	0.000574	0.0015	CcSEcCtD
Anastrozole—Anorexia—Vincristine—lymphatic system cancer	0.000574	0.0015	CcSEcCtD
Anastrozole—Body temperature increased—Bleomycin—lymphatic system cancer	0.000572	0.00149	CcSEcCtD
Anastrozole—Insomnia—Carmustine—lymphatic system cancer	0.000571	0.00149	CcSEcCtD
Anastrozole—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000567	0.00148	CcSEcCtD
Anastrozole—Paraesthesia—Carmustine—lymphatic system cancer	0.000567	0.00148	CcSEcCtD
Anastrozole—Mood swings—Methotrexate—lymphatic system cancer	0.000563	0.00147	CcSEcCtD
Anastrozole—Dyspnoea—Carmustine—lymphatic system cancer	0.000563	0.00147	CcSEcCtD
Anastrozole—Somnolence—Carmustine—lymphatic system cancer	0.000561	0.00146	CcSEcCtD
Anastrozole—Anorexia—Mitoxantrone—lymphatic system cancer	0.000559	0.00146	CcSEcCtD
Anastrozole—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000549	0.00143	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000549	0.00143	CcSEcCtD
Anastrozole—Decreased appetite—Carmustine—lymphatic system cancer	0.000549	0.00143	CcSEcCtD
Anastrozole—Insomnia—Vincristine—lymphatic system cancer	0.000545	0.00142	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000545	0.00142	CcSEcCtD
Anastrozole—Paraesthesia—Vincristine—lymphatic system cancer	0.000541	0.00141	CcSEcCtD
Anastrozole—Pain—Carmustine—lymphatic system cancer	0.00054	0.00141	CcSEcCtD
Anastrozole—Constipation—Carmustine—lymphatic system cancer	0.00054	0.00141	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000535	0.00139	CcSEcCtD
Anastrozole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000533	0.00139	CcSEcCtD
Anastrozole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000527	0.00137	CcSEcCtD
Anastrozole—Decreased appetite—Vincristine—lymphatic system cancer	0.000524	0.00137	CcSEcCtD
Anastrozole—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000523	0.00136	CcSEcCtD
Anastrozole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000522	0.00136	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00052	0.00136	CcSEcCtD
Anastrozole—Feeling abnormal—Carmustine—lymphatic system cancer	0.00052	0.00136	CcSEcCtD
Anastrozole—Fatigue—Vincristine—lymphatic system cancer	0.000519	0.00135	CcSEcCtD
Anastrozole—Asthenia—Bleomycin—lymphatic system cancer	0.000519	0.00135	CcSEcCtD
Anastrozole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000516	0.00135	CcSEcCtD
Anastrozole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000516	0.00135	CcSEcCtD
Anastrozole—Pain—Vincristine—lymphatic system cancer	0.000515	0.00134	CcSEcCtD
Anastrozole—Constipation—Vincristine—lymphatic system cancer	0.000515	0.00134	CcSEcCtD
Anastrozole—Pruritus—Bleomycin—lymphatic system cancer	0.000512	0.00133	CcSEcCtD
Anastrozole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00051	0.00133	CcSEcCtD
Anastrozole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000506	0.00132	CcSEcCtD
Anastrozole—Pain—Mitoxantrone—lymphatic system cancer	0.000502	0.00131	CcSEcCtD
Anastrozole—Constipation—Mitoxantrone—lymphatic system cancer	0.000502	0.00131	CcSEcCtD
Anastrozole—Abdominal pain—Carmustine—lymphatic system cancer	0.000499	0.0013	CcSEcCtD
Anastrozole—Body temperature increased—Carmustine—lymphatic system cancer	0.000499	0.0013	CcSEcCtD
Anastrozole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000493	0.00128	CcSEcCtD
Anastrozole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000484	0.00126	CcSEcCtD
Anastrozole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00048	0.00125	CcSEcCtD
Anastrozole—Abdominal pain—Vincristine—lymphatic system cancer	0.000476	0.00124	CcSEcCtD
Anastrozole—Body temperature increased—Vincristine—lymphatic system cancer	0.000476	0.00124	CcSEcCtD
Anastrozole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000466	0.00121	CcSEcCtD
Anastrozole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000465	0.00121	CcSEcCtD
Anastrozole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000464	0.00121	CcSEcCtD
Anastrozole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000464	0.00121	CcSEcCtD
Anastrozole—Vomiting—Bleomycin—lymphatic system cancer	0.00046	0.0012	CcSEcCtD
Anastrozole—Depression—Methotrexate—lymphatic system cancer	0.000457	0.00119	CcSEcCtD
Anastrozole—Rash—Bleomycin—lymphatic system cancer	0.000456	0.00119	CcSEcCtD
Anastrozole—Dermatitis—Bleomycin—lymphatic system cancer	0.000455	0.00119	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000454	0.00118	CcSEcCtD
Anastrozole—Asthenia—Carmustine—lymphatic system cancer	0.000453	0.00118	CcSEcCtD
Anastrozole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000444	0.00116	CcSEcCtD
Anastrozole—Sweating—Methotrexate—lymphatic system cancer	0.000439	0.00115	CcSEcCtD
Anastrozole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000433	0.00113	CcSEcCtD
Anastrozole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000432	0.00113	CcSEcCtD
Anastrozole—Asthenia—Vincristine—lymphatic system cancer	0.000432	0.00113	CcSEcCtD
Anastrozole—Diarrhoea—Carmustine—lymphatic system cancer	0.000432	0.00113	CcSEcCtD
Anastrozole—Nausea—Bleomycin—lymphatic system cancer	0.000429	0.00112	CcSEcCtD
Anastrozole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000421	0.0011	CcSEcCtD
Anastrozole—Dizziness—Carmustine—lymphatic system cancer	0.000417	0.00109	CcSEcCtD
Anastrozole—Haemoglobin—Methotrexate—lymphatic system cancer	0.000414	0.00108	CcSEcCtD
Anastrozole—Diarrhoea—Vincristine—lymphatic system cancer	0.000412	0.00107	CcSEcCtD
Anastrozole—Haemorrhage—Methotrexate—lymphatic system cancer	0.000411	0.00107	CcSEcCtD
Anastrozole—Hepatitis—Methotrexate—lymphatic system cancer	0.000411	0.00107	CcSEcCtD
Anastrozole—Pharyngitis—Methotrexate—lymphatic system cancer	0.000408	0.00106	CcSEcCtD
Anastrozole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000401	0.00105	CcSEcCtD
Anastrozole—Vomiting—Carmustine—lymphatic system cancer	0.000401	0.00105	CcSEcCtD
Anastrozole—Dizziness—Vincristine—lymphatic system cancer	0.000398	0.00104	CcSEcCtD
Anastrozole—Rash—Carmustine—lymphatic system cancer	0.000398	0.00104	CcSEcCtD
Anastrozole—Dermatitis—Carmustine—lymphatic system cancer	0.000398	0.00104	CcSEcCtD
Anastrozole—Headache—Carmustine—lymphatic system cancer	0.000395	0.00103	CcSEcCtD
Anastrozole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000389	0.00101	CcSEcCtD
Anastrozole—Vomiting—Vincristine—lymphatic system cancer	0.000383	0.000998	CcSEcCtD
Anastrozole—Rash—Vincristine—lymphatic system cancer	0.00038	0.00099	CcSEcCtD
Anastrozole—Dermatitis—Vincristine—lymphatic system cancer	0.00038	0.000989	CcSEcCtD
Anastrozole—Headache—Vincristine—lymphatic system cancer	0.000377	0.000984	CcSEcCtD
Anastrozole—Nausea—Carmustine—lymphatic system cancer	0.000375	0.000977	CcSEcCtD
Anastrozole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000373	0.000972	CcSEcCtD
Anastrozole—Rash—Mitoxantrone—lymphatic system cancer	0.00037	0.000964	CcSEcCtD
Anastrozole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00037	0.000963	CcSEcCtD
Anastrozole—Headache—Mitoxantrone—lymphatic system cancer	0.000368	0.000958	CcSEcCtD
Anastrozole—Alopecia—Methotrexate—lymphatic system cancer	0.000364	0.000948	CcSEcCtD
Anastrozole—Erythema—Methotrexate—lymphatic system cancer	0.000358	0.000934	CcSEcCtD
Anastrozole—Nausea—Vincristine—lymphatic system cancer	0.000358	0.000933	CcSEcCtD
Anastrozole—Dysgeusia—Methotrexate—lymphatic system cancer	0.000351	0.000914	CcSEcCtD
Anastrozole—Nausea—Mitoxantrone—lymphatic system cancer	0.000349	0.000908	CcSEcCtD
Anastrozole—Back pain—Methotrexate—lymphatic system cancer	0.000346	0.000903	CcSEcCtD
Anastrozole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000332	0.000866	CcSEcCtD
Anastrozole—Anaemia—Methotrexate—lymphatic system cancer	0.000331	0.000863	CcSEcCtD
Anastrozole—Malaise—Methotrexate—lymphatic system cancer	0.000323	0.000842	CcSEcCtD
Anastrozole—Leukopenia—Methotrexate—lymphatic system cancer	0.000321	0.000836	CcSEcCtD
Anastrozole—Cough—Methotrexate—lymphatic system cancer	0.000313	0.000815	CcSEcCtD
Anastrozole—Chest pain—Methotrexate—lymphatic system cancer	0.000305	0.000795	CcSEcCtD
Anastrozole—Myalgia—Methotrexate—lymphatic system cancer	0.000305	0.000795	CcSEcCtD
Anastrozole—Arthralgia—Methotrexate—lymphatic system cancer	0.000305	0.000795	CcSEcCtD
Anastrozole—Discomfort—Methotrexate—lymphatic system cancer	0.000301	0.000785	CcSEcCtD
Anastrozole—Confusional state—Methotrexate—lymphatic system cancer	0.000295	0.000768	CcSEcCtD
Anastrozole—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000292	0.000762	CcSEcCtD
Anastrozole—Infection—Methotrexate—lymphatic system cancer	0.00029	0.000757	CcSEcCtD
Anastrozole—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000283	0.000737	CcSEcCtD
Anastrozole—Anorexia—Methotrexate—lymphatic system cancer	0.000279	0.000726	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000266	0.000694	CcSEcCtD
Anastrozole—Insomnia—Methotrexate—lymphatic system cancer	0.000264	0.000689	CcSEcCtD
Anastrozole—Paraesthesia—Methotrexate—lymphatic system cancer	0.000263	0.000684	CcSEcCtD
Anastrozole—Dyspnoea—Methotrexate—lymphatic system cancer	0.000261	0.000679	CcSEcCtD
Anastrozole—Somnolence—Methotrexate—lymphatic system cancer	0.00026	0.000677	CcSEcCtD
Anastrozole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000257	0.000671	CcSEcCtD
Anastrozole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000254	0.000662	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000252	0.000658	CcSEcCtD
Anastrozole—Fatigue—Methotrexate—lymphatic system cancer	0.000252	0.000657	CcSEcCtD
Anastrozole—Pain—Methotrexate—lymphatic system cancer	0.00025	0.000652	CcSEcCtD
Anastrozole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000241	0.000628	CcSEcCtD
Anastrozole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000239	0.000623	CcSEcCtD
Anastrozole—Urticaria—Methotrexate—lymphatic system cancer	0.000232	0.000605	CcSEcCtD
Anastrozole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000231	0.000602	CcSEcCtD
Anastrozole—Body temperature increased—Methotrexate—lymphatic system cancer	0.000231	0.000602	CcSEcCtD
Anastrozole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000215	0.000561	CcSEcCtD
Anastrozole—Asthenia—Methotrexate—lymphatic system cancer	0.00021	0.000547	CcSEcCtD
Anastrozole—Pruritus—Methotrexate—lymphatic system cancer	0.000207	0.000539	CcSEcCtD
Anastrozole—Diarrhoea—Methotrexate—lymphatic system cancer	0.0002	0.000521	CcSEcCtD
Anastrozole—Dizziness—Methotrexate—lymphatic system cancer	0.000193	0.000504	CcSEcCtD
Anastrozole—Vomiting—Methotrexate—lymphatic system cancer	0.000186	0.000484	CcSEcCtD
Anastrozole—Rash—Methotrexate—lymphatic system cancer	0.000184	0.00048	CcSEcCtD
Anastrozole—Dermatitis—Methotrexate—lymphatic system cancer	0.000184	0.00048	CcSEcCtD
Anastrozole—Headache—Methotrexate—lymphatic system cancer	0.000183	0.000477	CcSEcCtD
Anastrozole—Nausea—Methotrexate—lymphatic system cancer	0.000174	0.000453	CcSEcCtD
